Lilly’s Covid-19 Antibody Helps Patients Rid their Systems of Virus Sooner

Lilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placebo. A drug being developed by Eli Lilly helped sick patients rid their systems of the virus that causes Covid-19 sooner and may have prevented them from landing in the hospital, according to newly released data. The drug is...

Behavioral Strategies to Prevent and Mitigate COVID-19 Infection | Semantic Scholar

The single stranded RNA virus SARS-CoV-2 has caused a massive addition to the already leading global cause of mortality, viral respiratory tract infections. Characterized by and associated with early and deleteriously enhanced production of pro-inflammatory cytokines by respiratory epithelial cells, severe COVID-19 illness has the potential to inflict acute respiratory distress syndrome and even death....